Skip to main content
Premium Trial:

Request an Annual Quote

Johns Hopkins Purchases Sequenom's MassArray

NEW YORK (GenomeWeb News) – Sequenom said today that a research lab at Johns Hopkins University has purchased a MassArray system.
 
The San Diego-based firm said that the DNA Diagnostic Lab of the McKusick-Nathans Institute of Translational Clinical Research at the university will use the MassArray platform for genotyping, clinical genotyping, DNA methylation, and quantitative gene expression analysis.
 
Garry Cutting, director of the DNA Diagnostic Lab, said that the system will “facilitate efficient translation of genomic discoveries into clinical application.”

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.